In the dynamic realm of biopharmaceutical development, custom peptide synthesis and manufacturing stand as cornerstones of innovation. From fundamental research to cutting-edge therapeutic applications, peptides offer unparalleled versatility and specificity. Selecting a reliable contract develop

Bachem has shocked the pharmaceutical industry with its massive $2.3 billion acquisition of AmWiner, marking one of the largest deals in the peptide therapeutics sector this year. This strategic takeover signals Bachem's ambitious plans to dominate the growing market for peptide-based medications